Ligand validation:5QIV

EDO: 1,2-ETHANEDIOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5QIV_EDO_A_601	86%	88%	0.084	0.953	0.6	0.08	-	-	0	0	100%	1
5QIV_EDO_A_602	74%	74%	0.113	0.942	0.17	0.82	-	-	0	0	100%	1
5QIV_EDO_A_603	29%	85%	0.204	0.861	0.3	0.44	-	-	1	0	100%	1
5QIV_EDO_A_604	22%	73%	0.32	0.937	0.47	0.54	-	-	3	0	100%	1
5QIV_EDO_A_605	9%	35%	0.343	0.833	1.15	1.48	-	-	6	0	100%	1
5QIT_EDO_A_305	90%	58%	0.067	0.949	0.25	1.31	-	-	0	0	100%	1
5QIP_EDO_A_303	78%	41%	0.082	0.925	0.48	1.84	-	1	0	0	100%	1
4KXW_EDO_A_1003	100%	73%	0.033	0.993	0.64	0.4	-	-	0	0	100%	1
7CJO_EDO_B_1210	100%	83%	0.038	0.99	0.47	0.32	-	-	0	0	100%	1
4O78_EDO_A_202	100%	86%	0.043	0.992	0.4	0.33	-	-	0	0	100%	1
6QRS_EDO_A_401	100%	83%	0.045	0.991	0.47	0.31	-	-	0	0	100%	1
1EB6_EDO_A_1180	100%	64%	0.041	0.986	0.62	0.72	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.